Pharmanetics has nearly $10 million to use in driving sales of its ENOX test for blood coagulation.

The Raleigh firm said Thursday it raised $9.58 million through a private placement of stock at $6 a share plus warrants to purchase an additional 510,932 common shares at $7.12. The company said much of the cash would be used for the ENOX campaign.

Pharmanetics (Nasdaq: PHAR) stock closed at $6 on Thursday, down $1.21.